Ocular Trauma
Conditions
Interventions
The treatment group:Nano-silver emergency eye patches
The control group:Atrauman nanosilver dressings
Sponsors
Hainan Hospital of PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) volunteers for the trial who signed an informed consent form; 2) inpatients or outpatients between the ages of 18 and 85 years who received treatment within 6 hours after injury or within one week after the onset of keratitis; 3) patients with clean, potentially contaminated, or contaminated ocular surface traumas; 4) women of childbearing age who agreed to take effective contraceptive measures during the study period.
Exclusion criteria
Exclusion criteria: 1) individuals not consenting to participate in the trial, 2) participants with known allergies to any component of the product, 3) pregnant women, 4) patients with severe conditions that precluded definitive evaluations of the efficacy and safety, and 5) patients deemed unsuitable for the experiment by other researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of ocular pain;The frequency of ocular pain;The severity of photophobia;The frequency of photophobia;The severity of foreign-body sensation;The frequency of foreign-body sensation;The severity of itchiness;The frequency of itchiness;The severity of discharge;The frequency of discharge; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound cleanliness;Wound healing; | — |
Countries
China
Contacts
Public ContactHuang Houbin
Hainan Hospital of PLA General Hospital
Outcome results
None listed